Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may mimic faster mitochondrial removal

After suppression of , may mimic faster mitochondrial removal, while slower fatal-tumor growth extends life. Independent confirmation of faster removal of whole would reject the optical explanation.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Biological function

The biological function description is being prepared

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Reporter photophysics and false mediation
Goal
Перечень причинно самостоятельных идей серебряных пуль для продления жизни
Competing hypotheses
4
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
7 / 10Few new entities
7 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Indicator or biomarker

    signal

    A signal that changes with and the amount of accumulated

    Where this hypothesis actsAfter suppression, with already accumulated in

    Hypotheses on this target 1
    mt-Keima signalTelling states apart. Hypotheses on this target 11Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart1
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Calibrate the signal to distinguish acidity effects from mitochondrial clearance

    With whatInstrument or assay

    HowMeasure acidity and accumulated independently, then compare with independent tracking of labelled mitochondrial delivery and destruction

    Possible result

    Expected disappearance of the apparent increase in after

    From the recordИзменение сигнала mt-Keima объясняется независимо измеренной кислотностью и количеством ранее накопленного репортёра.

  2. Enzyme

    A protein whose suppression reduces excessive transcription of ribosomal genes in the proposed pathway

    Where this hypothesis actsIn the presence of a lethal tumour, including during actual blockade

    Hypotheses on this target 4
    mTORInhibition. Hypotheses on this target 44Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition4
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Inhibition

    Suppress

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible lifespan extension through delayed lethal tumour growth without broad functional improvement

    From the recordПри этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез.

  3. Rhythm or programme

    The delivery of to and removal of whole

    Where this hypothesis actsDuring suppression, when testing whether mediates lifespan extension

    Hypotheses on this target 3
    MitophagyInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 22Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation2
    • Function preservation
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Inhibition

    Block to test whether the lifespan benefit persists

    With whatControlled genetic model

    HowSwitch off a selected, unnamed gene and independently track labelled mitochondrial delivery and destruction to verify blockade beyond acidity effects

    Possible result

    Expected persistence of lifespan extension despite verified blockade

    From the recordОн сохраняется при действительной блокаде митофагии и повышает SPV_12

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαmTOR. Hypotheses on this target 4mTOR
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionMitophagy. Hypotheses on this target 3Mitophagy
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burdenmt-Keima signal. Hypotheses on this target 1mt-Keima signal

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

A longer life after treatment could reflect a later death from one tumor without broader protection against aging. The unexpected move is to propose that an apparent increase in cellular cleanup partly comes from a change in the measuring signal itself. This is a hypothesis generated by the pipeline, not a measured explanation of the survival benefit.

The proposed mechanism, link by link
  1. Suppressing is proposed to change acidity inside the cell’s disposal compartments.
  2. Changed acidity alters the signal from mitochondrial material already delivered there, rather than increasing the rate of whole-mitochondrion removal.
  3. Disabling the selected gene is proposed to alter acidity further, making a signal change resemble successful blocking of mitochondrial removal.
  4. Separately, suppressing is proposed to slow the growth of a lethal tumor directly.
  5. Slower tumor growth postpones death even when mitochondrial removal is genuinely blocked, while long-term functions unrelated to tumors remain unchanged.
A picture for it

A warehouse changes its lighting, making the same pile of discarded equipment look larger in photographs. The photographs could then suggest that more equipment is arriving even when the delivery rate has not changed.

Where the picture breaks: The biological signal depends on acidity and the fate of the marker inside cells. The picture does not establish that acidity actually changes under the proposed treatment, and it does not explain the separate claim about tumor growth.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so acting on a shared cause could benefit several bodily systems at once.

    Rests on: The goal assumes that mutually reinforcing aging processes offer a possible shared point of intervention.

    Assumption

    The supplied goal takes the existence of a useful shared causal target as a possibility to explore; it supplies no evidence that such a target has been identified.

  2. Goal pillarstep 02 of 04

    The intended output is a collection of life-extension ideas that act through distinct causes.

    Rests on: The master question explicitly requests ideas for interventions against shared causes of aging.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Life extension after suppressing might survive the blocking of , the delivery and breakdown of through the cell’s disposal system, because treatment delays only one cause of death while damage continues to reinforce itself across bodily systems.

    Rests on: The search for interventions with benefits across systems motivates separating broad protection from postponement of one fatal disease.

    Leap

    The preceding stages do not supply the move to , a life-extension effect in a specified population, or as its proposed necessary intermediate. The screened sources do not establish that survival benefit or its dependence on mitochondrial removal.

  4. Hypothesisstep 04 of 04

    An apparent increase in mitochondrial removal is proposed to arise partly from changing acidity inside , cellular compartments that break down delivered material. A , a detectable marker used to follow mitochondrial material, could change its signal after arriving there without any faster removal of whole . Disabling the selected gene could also alter acidity, while a separate slowing of tumor growth could account for longer life.S5

    Rests on: The gap question supplies the possibility of survival benefits without mitochondrial removal as the necessary intermediate. S5, in Redox Biology in 2025, reports an acidity-sensitive mitochondrial signal and altered in heart muscle cells subjected to oxygen deprivation and restoration; it does not establish the proposed measurement artifact under suppression or the tumor-based explanation of longer life.

    Supported by literature

What is carried, and what is not. Of the five proposed links listed here, one has partial direct support from the screened literature: S5, in Redox Biology in 2025, supports acidity sensitivity of the measurement in stressed heart muscle cells, but not a treatment-induced signal change at an unchanged removal rate. The supplied sources do not establish the proposed sequence end to end or its separate tumor-to-survival explanation.S5

Where the reasoning is carried by something unstated · 2
  • Master question. The supplied goal takes the existence of a useful shared causal target as a possibility to explore; it supplies no evidence that such a target has been identified.
  • Gap question. The preceding stages do not supply the move to , a life-extension effect in a specified population, or as its proposed necessary intermediate. The screened sources do not establish that survival benefit or its dependence on mitochondrial removal. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A change in , an acidity-sensitive fluorescent marker of mitochondrial material, could be mistaken for a change in the rate of mitochondrial removal. Agreement between two acidity-sensitive markers would preserve the same ambiguity. What closes it: Acidity and the amount of previously accumulated marker must be measured independently, and the signal must be calibrated against them. Delivery and subsequent breakdown of labeled mitochondrial material must also be followed with measurements that do not share the same dependence on acidity.
  • A signal change after disabling a gene could be treated as proof that mitochondrial removal was blocked, even if the gene changed only the measurement conditions. Faster replacement of individual mitochondrial proteins could also be mistaken for removal of whole . What closes it: Successful blocking must be established by tracking delivery and breakdown of whole independently of acidity. The selected gene and the criterion for successful blocking are not specified in the supplied material and must be fixed before interpreting survival.
  • Longer survival accompanied by slower tumor growth could be credited entirely to direct tumor suppression even if improved breathing, greater resistance to cell injury, fewer new cellular injuries, or better removal of damaged proteins also contributes. What closes it: Tumor growth and causes of death must be assessed alongside long-term functions unrelated to tumors, selected in advance. The hypothesis requires excluding the rival mechanisms, but the supplied material does not specify how their contributions would be removed or verified.

What would make this wrong. Independent evidence that treatment accelerates removal of whole would refute the hypothesis’s unchanged-removal claim, even if acidity also affects the . Loss of the survival benefit after a verified, specific block of mitochondrial removal would contradict its claimed independence from that process. Reproducible long-term improvement in the preselected functions unrelated to tumors would contradict the predicted absence of broader functional benefit.

What it would change. If this account held, the observed survival benefit would not establish that treatment interrupts a shared cause of aging across bodily systems. Work seeking such a shared intervention would need to distinguish delayed tumor death from broader functional protection and verify mitochondrial removal independently of the acidity-sensitive signal. Even then, this explanation would not establish effects in humans or across other tissues and causes of death; the supplied rivals mention old mice, but the endpoint does not specify its population, duration, or the meanings of its two named outcome measures.

Sources read · 7

4 literature searches, 6 full texts, 4 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1BackgroundAbstract only

PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. · Autophagy · 2019

“Mitophagy plays a crucial role in eliminating damaged mitochondria, and is governed by the PINK1 (PTEN induced putative protein kinase 1)-PRKN (parkin RBR E3 ubiquitin protein ligase) pathway.”

Does not settle: Источник оставляет открытыми влияние подавления mTOR на кислотность лизосом и сигнал митохондриального репортёра, скорость удаления митохондрий, связь выключения гена с кислотностью, рост опухоли, продолжительность жизни и показатели SPV_11 и SPV_12.

S2Background

AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming. · Journal of molecular cell biology · 2026

“AMPKα deficiency in HSCs prevents the metabolic switch necessary for the induction of oxidative phosphorylation via mitophagy.”

Does not settle: This source does not establish effects of mTOR inhibition, lysosomal acidity or reporter artifacts, mitochondrial-removal rates, tumor growth, lifespan, SPV_11 or SPV_12, or whether mitophagy blockade preserves any lifespan benefit.

S4Background

MG132-mediated inhibition of rabies virus replication via the Nrf2/SQSTM1/PINK1/Parkin autophagy pathway. · Virology journal · 2026

“Rapamycin-induced autophagy and Parkin-mediated mitophagy could also be inhibited by MG132.”

Does not settle: Источник не оценивает кислотность лизосом, оптические артефакты митохондриального репортёра, скорость удаления митохондрий, генетическую блокаду митофагии, опухолевый рост или показатели SPV_11 и SPV_12.

S5Partly answers it

Peroxiredoxin Ⅲ mitigates mitochondrial H2O2-mediated damage and supports quality control in cardiomyocytes under hypoxia-reoxygenation stress. · Redox biology · 2025

“The pH-sensitive fluorescence shift of mt-Keima from green (neutral pH) to red (acidic lysosomal pH) enables reliable tracking of mitochondrial degradation.”

Does not settle: Источник показывает pH-зависимость сигнала mt-Keima и изменение кислотности лизосом при дефиците PrxIII в кардиомиоцитах при гипоксии-реоксигенации. Он не изучает подавление mTOR, опухоли, продолжительность жизни, SPV_11 или SPV_12, а также не устанавливает, что изменение сигнала происходит при неизменной скорости удаления митохондрий или сохраняется при блокаде митофагии.

S6BackgroundAbstract only

Everolimus alleviates cognitive dysfunction in 5×FAD mice by regulating mitochondrial function and oxidative stress. · European journal of pharmacology · 2025

“Although these findings suggest an mTOR-dependent mechanism involving mitochondrial protection, the study did not investigate autophagy or mitophagy pathways, a limitation that should be addressed in future research.”

Does not settle: Источник не устанавливает влияние подавления mTOR на митофагию, кислотность лизосом, оптические артефакты репортёров, роль выбранного гена, удаление митохондрий, опухоль, продолжительность жизни или показатели SPV_11 и SPV_12.

S8BackgroundAbstract only

Acid triggering highly-efficient release of reactive oxygen species to block mitochondrial-mediated homeostasis maintenance for accelerating cell death. · Analytica chimica acta · 2025

“the damaged mitochondria activate the mitophagy process, which further boosts the ROS generation of the TTBI owing to the acidic environment in the lysosome”

Does not settle: Источник не исследует подавление mTOR, оптические репортёры, скорость удаления митохондрий, выключение гена, продолжительность жизни, опухолевый рост, SPV_11 или SPV_12.

S10Background

Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. · Autophagy · 2021

“Transcriptome analysis and other results demonstrated that ER stress and the ATF4-DDIT3-TRIB3-AKT-MTOR axis downstream of TRPV4 were involved in CBD-induced mitophagy in glioma cells.”

Does not settle: This source does not establish lysosomal-acidity optical effects, unchanged mitochondrial-removal rates, gene-dependent acidity artifacts, mitophagy blockade, lifespan effects, or SPV_11/SPV_12 outcomes.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does blocking a growth-control protein still extend mouse life when damaged cell powerhouses cannot be cleared?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сохранится ли продление жизни при подавлении после выключения предполагаемого , , если межсистемное усиление повреждений останется прежним, а весь выигрыш объяснит отсрочка одной причины смерти?

What this question is asking

The question asks whether removing damaged energy-producing structures inside cells is necessary for a treatment to extend mouse life. It concerns suppression of mammalian target of (), a protein involved in controlling cell growth, after disabling , the process that removes those structures. The relevant comparison is whether suppression still increases remaining lifespan relative to no suppression when this removal process is disabled, compared with when it remains available. The question also considers a conditional explanation: damage in different body systems might continue to worsen other systems' damage, while the entire survival benefit comes from postponing just one cause of death.

What the terms mean
Mammalian target of rapamycin (mTOR)
A protein involved in controlling cell growth. Suppression means reducing its activity; the question asks whether the resulting lifespan effect requires removal of damaged cellular powerhouses.
Mitochondria
Structures inside cells involved in producing usable energy, described here as cellular powerhouses. Their removal is the proposed link between treatment and longer life.
Mitophagy
The cellular process that removes , including damaged ones. The question treats it as a possible necessary step in the lifespan effect, which the supplied sources do not establish.
Autophagy
The broader cellular process for removing and recycling material within cells. is the -focused form; a finding about the broader process does not automatically establish the particular role of .
Mediator and mediation
A mediator is an intermediate process through which an intervention causes an outcome. Here, mediation would mean that suppression of extends life through its effect on , rather than the two simply being associated.
Intersystem damage amplification
The proposed process in which damage in one body system worsens damage in another. Its persistence during treatment is a condition considered by the question, not a finding established by the supplied sources.
Rapamycin
The treatment evaluated in the mouse lifespan findings quoted in S2. Those findings describe survival responses but do not establish the proposed role of .
Corylin
The compound studied in S3. The supplied quotation reports a lifespan benefit in female mice without a comparable benefit in males.
Median lifespan
The time by which half of a studied group has died. It summarizes survival and does not identify which causes of death changed.
Survival rate at a stated age
The proportion of a group still alive at that age. S3 reports a comparison at 125 weeks; the supplied quotation does not give the underlying proportions.
Mouse strain
A mouse breeding line with a particular inherited background. S2 reports that strain influences the size of the lifespan response.
Kisspeptin-10
The molecule used in S5 to stimulate cellular removal processes. The supplied quotation describes a route independent of , so it does not establish mediation of a treatment that suppresses .
Cellular signaling
Processes through which activity in one part of a cell changes activity elsewhere in it. A signaling connection alone does not establish an effect on whole-animal lifespan.
Human neuronal cell line
Human cells maintained in laboratory culture and used to study nerve-cell processes. Findings in these cells do not by themselves establish survival effects in an animal.
Hippocampus and cultured hippocampal tissue
The hippocampus is a brain region. Cultured hippocampal tissue is tissue from that region maintained outside the animal; S5 includes this preparation alongside cell cultures and aging rats.
What the question takes for granted
Premise could not be checked
suppression is associated with longer mouse survival, is its proposed cellular mediator, and the survival gain might occur with unchanged intersystem damage amplification because only one cause of death is delayed.

The proposed explanation places removal of damaged cellular powerhouses between blocking a growth-control protein and longer life. It contrasts protection across several body systems with a scenario in which damage still spreads between systems but one fatal condition occurs later. Establishing these links would distinguish a shared protective process from a narrower explanation of longer survival.

S2 reports generally favorable mouse lifespan findings for , and S3 reports longer life in female mice receiving corylin. Neither supplied quotation establishes that removal of damaged cellular structures mediates those benefits. S5 instead reports stimulation of that removal through a route independent of ; it does not establish the proposed mediation. None of the supplied sources establishes unchanged damage amplification between systems or a survival gain fully explained by delaying one cause of death. Those last conditions are hypothetical in the question, and this background-focused selection is too limited to establish or refute the complete premise.S2S3S5

The same question asked without the part nothing read establishes:

  • Does suppressing the growth-control protein extend mouse life when removal of damaged cellular powerhouses is disabled?
  • Does longer mouse life under suppression of the growth-control protein reflect lasting benefits across several body systems or postponement of one cause of death?
What turns on the answer
  • The lifespan benefit persists Under the question's assumption that removal of damaged cellular powerhouses has been disabled, a persisting benefit would mean that this removal is not necessary for the entire survival effect. If postponement of one cause of death accounts for all of that benefit, longer life would not by itself demonstrate protection across several body systems.
  • The lifespan benefit disappears Losing the benefit would be consistent with the removal process being necessary for the survival effect in the stated conditions. That result alone would still not establish that the process protects several systems or interrupts damage spreading between them.
  • The lifespan benefit becomes smaller A smaller benefit would be consistent with the removal process contributing to, but not fully accounting for, longer survival. The remaining benefit would still need to be distinguished from the question's alternative explanation of postponing one cause of death.
Why it matters

The proposed explanation links suppression of the growth-control protein to removal of damaged cellular structures, then to lasting benefits across several body systems, and finally to longer life. Each connection matters because longer survival alone does not establish the preceding steps. Under the question's alternative explanation, postponing one fatal disease could extend life while damage elsewhere continues. Mistaking that outcome for protection across several systems would overstate what the survival findings establish.

What is already established

Подавление уровня связано с ; уровня показано на клетках.

What would have to be true

Выигрыш оставшейся жизни должен сопровождаться устойчивой пользой нескольким системам и проверенным общим за единый .

What is missing

Не установлено, объясняет ли многосистемный выигрыш жизни; подавление отдельной смертельной патологии может воспроизводить наблюдаемую .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Предполагаемое усиление после подавления частично представляет собой оптический эффект изменения . Уже доставленный туда митохондриальный меняет сигнал, хотя скорость удаления целых остаётся прежней. может дополнительно менять кислотность и тем самым создавать ложную картину выключения . Реальный выигрыш жизни в этой версии обусловлен прямым торможением роста смертельной опухоли. Он сохраняется при действительной и повышает , но общего и согласованного улучшения не возникает.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Изменение сигнала объясняется независимо измеренной кислотностью и количеством ранее накопленного . После соответствующей увеличение исчезает; независимое отслеживание доставки и разрушения также не выявляет ускорения. При этом подавление замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых независимыми методами опровергает оптическую часть гипотезы.

States a measurable outcome; comparing rivals needs more conditions. The prediction states measurable qualitative outcomes and an explicit rejection condition for its optical component. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Можно сочетать кислотности, наблюдение доставки и отслеживание судьбы заранее материала. Два , оба зависящие от кислотности, не дают независимой проверки. Обновление отдельных также нельзя автоматически приравнивать к удалению целой .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Изменение сигнала объясняется независимо измеренной кислотностью и количеством ранее накопленного . После соответствующей увеличение исчезает; независимое отслеживание доставки и разрушения также не выявляет ускорения. При этом подавление замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых независимыми методами опровергает оптическую часть гипотезы.

  • What would separate them

    Rapamycin may extend life by changing calcium control of breathing-muscle contraction predicts: При подтверждённой сохраняет выигрыш оставшейся жизни и повышает устойчивость к повторным сокращениям. Сопоставимое подавление генетическим способом этого результата не воспроизводит. , сохраняющий необходимое и не подавляющий , воспроизводит оба эффекта. Избирательное устранение отменяет выигрыш при сохранённом подавлении . Сохранение пользы генетического подавления после такого устранения опровергает гипотезу.

  • What would separate them

    Growth-signal inhibition may release a brake on protein kinase B and limit cell death predicts: После сохраняются краткий ответ , уменьшение после повторной нагрузки и замедление функционального ухудшения нескольких систем. Избирательное устранение вызванного лечением ответа отменяет эти эффекты при сопоставимом подавлении . Модель, построенная по ответам на одиночные слабые нагрузки, заранее предсказывает меньший пик повреждения при их сочетании. Если защита сохраняется при устранённом ответе либо измеренный ответ усиливает повреждение, гипотеза отвергается.

  • What would separate them

    Reducing ribosomal gene transcription may protect tissues by limiting genome damage predicts: При подавленной лечение уменьшает и новые в до появления функциональной пользы. Направленное удаление патологических воспроизводит защиту и уменьшает дополнительный эффект в диапазоне, свободном от . Избирательное восстановление исходного уровня при сохранённом подавлении отменяет защиту. Если лечение сохраняет функциональную и жизненную пользу при экспериментально восстановленном , эта версия отвергается.

  • What would separate them

    Ubiquitin-dependent protein disposal may preserve tissue function despite defective mitophagy predicts: После сохраняются ускоренное разрушение заранее повреждённых и функциональная польза. Устранение именно вызванного лечением прироста отменяет пользу, хотя подавление и изменения сохраняются. Независимое восстановление возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.